Table 3.
Comparison of number and percentage of women and infants receiving PMTCT services, before (2006–2010) and during (2011–2015) the EGPAF-CIFF CPM project
| Indicator | Number of women and infants receiving PMTCT services (numerator) and percentage, out of those eligible (denominator) in pre-intervention and intervention period | % change in number of women & infants receiving PMTCT services before and during the projecta | Person’s Chi2 test p-value comparing % women & infants receiving PMTCT services before and during the project | |
|---|---|---|---|---|
| Pre-Intervention Period (2006–2010) |
Intervention Period (2011–2015) |
|||
| Pregnant women booked for ANC |
59% (1,176,003/1,985,076) |
97% (2,048,283/2,105,205) |
74% | < 0.001 |
| Pregnant women tested for HIV in ANC |
80% (941,293/1,176,003) |
99% (1,953,814/1,972,936) |
108% | < 0.001 |
| HIV-positive pregnant women dispensed ARVS |
24% (34,330/141,064) |
74% (123,547/167,839) |
260% | < 0.001 |
| HIV-positive pregnant women CD4 tested |
11% (15,543/141,064) |
62% (123,578/197,788) |
695% | < 0.001 |
| HIV-positive pregnant women initiated ART |
2% (3287/141,064) |
42% (83,494/197,788) |
2440% | < 0.001 |
| HIV-exposed infants initiated ARV prophylaxis |
70% (98,898/141,064) |
85% (244,814/287,543) |
148% | < 0.001 |
| Infants HIV tested using DNA PCR < 2 months |
9% (12,494 /141,064) |
58% (167,291/287,543) |
1239% | < 0.001 |
aMeasures the change in the numbers provided PMTCT services between the pre-intervention and intervention period